Key result
Statin therapy exerts cholesterol-independent pleiotropic effects, including improving endothelial function, increasing circulating endothelial progenitor cells, and promoting angiogenesis.
Answers are grounded in this paper and cite their sources.
Statins exhibit pleiotropic, cholesterol-independent effects including improved endothelial function, plaque stabilization, and mobilization of endothelial progenitor cells.
ecause serum cholesterol level is strongly associated with coronary heart disease, it has been generally assumed that cholesterol reduction by 3-hydroxy-3methylglutaryl-coenzyme A reductase inhibitors or statins is the predominant mechanism underlying their beneficial effects.However, large prospective trials with statins suggest that these agents may have beneficial effects in cardiovascular disease in addition to their cholesterol-lowering effects.These so-called cholesterol-independent or "pleiotropic" effects include improving or restoring endothelial function, decreasing oxidative stress and inflammation, enhancing the stability of atherosclerotic plaques, and inhibiting the thrombogenic response in the vascular wall (Table ).Many of these effects may explain some of the rapid actions of statin therapy on tissue perfusion in acute coronary syndrome and ischemic stroke, irrespective of baseline cholesterol levels.Recently, statins have also been found to increase the number of circulating endothelial progenitor cells (EPCs). 1 EPCs augment ischemia-induced neovascularization, 2 accelerate re-endothelialization after carotid balloon injury, 3 and improve post-ischemic cardiac function.4 Indeed, statins induce angiogenesis by promoting the proliferation, migration, and survival of circulating EPCs. 5 In patients with stable coronary artery disease, administration of statins for 4 weeks augmented the number of circulating EPCs and enhanced functional capacity in patients with stable coronary artery disease.6 These findings agree with earlier data showing that statins rapidly mobilize EPCs from the bone marrow and accelerates vascular structure formation via activation of phosphatidylinositol 3-kinase/protein kinase Akt and endothelial nitric oxide synthase.5,7,8 These angiogenic effects were observed at lower concentrations of statins and were cholesterol-independent.At higher concentrations, statins appear to have an antiangiogenic effect, 9,10 suggesting a biphasic effect of statins on angiogenesis.11 However, this suggestion remains controversial since higher doses of statins have also been shown to be angiogenic.12 The clinical benefits of statins also extend beyond cardiovascular disease to include a reduction in the risk of dementia, 13 Alzheimer disease, 14 multiple sclerosis, 15 osteoporo-The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.
No takes yet. Share an insight, caveat, or question.
James K. Liao (2004) conducted an editorial in Cardiovascular disease. Statin therapy was evaluated. Statin therapy exerts cholesterol-independent pleiotropic effects, including improving endothelial function, increasing circulating endothelial progenitor cells, and promoting angiogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: